NuVasive Inc (NASDAQ:NUVA)
During the Trading Day
| 35.09 |  +1.03 / +3.02% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 35.09 |  0.00 / 0.00% |
Volume: 11.9K |
Latest NUVA News | Press Releases
No recent news for NuVasive Inc.
Today’s Trading
| Previous close | 34.06 |
| Today’s open | 34.12 |
| Day’s range | 33.92 - 35.31 |
| Volume | 493,916 |
| Average volume (3 months) | 359,844 |
| Market cap | $1.6B |
| Dividend yield | -- |
Data as of 4:00pm ET, 07/28/2014
Growth & Valuation
| Earnings growth (last year) | +142.86% |
| Earnings growth (this year) | -11.03% |
| Earnings growth (next 5 years) | +12.93% |
| Revenue growth (last year) | +10.47% |
| P/E ratio | NM |
| Price/Sales | 2.10 |
| Price/Book | 2.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IARTIntegra LifeSciences... | +0.07 | +0.15% |
| MASIMasimo Corp | -0.06 | -0.25% |
| HAEHaemonetics Corp | +0.35 | +0.98% |
| EXASExact Sciences Corp | -0.41 | -2.56% |
Data as of 4:00pm ET, 07/28/2014
Financials
| Next reporting date | July 30, 2014 |
| EPS forecast (this quarter) | $0.25 |
| Annual revenue (last year) | $685.2M |
| Annual profit (last year) | $7.9M |
| Net profit margin | 1.15% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Alexis V. Lukianov |
President & Chief Operating Officer Keith C. Valentine |
Corporate headquarters San Diego, California |
Forecasts
.
